[DNLI] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
27-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 4.47%
YoY- -31.11%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 1,267 294,123 35,141 10,283 3,559 52,480 42,141 -90.31%
PBT -99,353 183,383 -109,781 -98,684 -103,299 -58,767 -65,220 32.35%
Tax 2,257 -2,285 -10,047 -6 2,114 27 -1,278 -
NP -99,353 183,383 -109,781 -98,678 -103,299 -58,794 -63,942 34.11%
Tax Rate - 1.25% - - - - - -
Total Cost 100,620 110,740 144,922 108,961 106,858 111,274 106,083 -3.46%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -7,841.59 62.35 -312.40 -959.62 -2,902.47 -112.03 -151.73 1284.13%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.72 1.34 -0.80 -0.74 -0.84 -0.48 -0.52 24.20%
EPS Diluted -0.72 1.30 -0.80 -0.74 -0.84 -0.48 -0.52 24.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.